AUROBINDO PHARMA LTD FDA Approval ANDA 207753

ANDA 207753

AUROBINDO PHARMA LTD

FDA Drug Application

Application #207753

Application Sponsors

ANDA 207753AUROBINDO PHARMA LTD

Marketing Status

Over-the-counter001

Application Products

001CAPSULE;ORALEQ 200MG FREE ACID AND POTASSIUM SALT0IBUPROFENIBUPROFEN

FDA Submissions

UNKNOWN; ORIG1AP2018-06-29STANDARD

Submissions Property Types

ORIG1Null7

CDER Filings

AUROBINDO PHARMA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 207753
            [companyName] => AUROBINDO PHARMA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"IBUPROFEN","activeIngredients":"IBUPROFEN","strength":"EQ 200MG FREE ACID AND POTASSIUM SALT","dosageForm":"CAPSULE;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/29\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-06-29
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.